Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Tables)

v3.24.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities

The following shares were excluded in the computation of the diluted net loss per share because their effect is anti-dilutive:

 

    2023     2022  
    December 31,  
    2023     2022  
Warrants to purchase common stock     304,962       77,909  
Options to purchase common stock     126,265       54,348  
Total anti-dilutive securities     431,227       132,257